S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
Log in
OTCMKTS:ENZN

Enzon Pharmaceuticals SEC Filings & 10K Form

$0.59
-0.02 (-3.27 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.53
Now: $0.59
$0.62
50-Day Range
$0.30
MA: $0.52
$0.84
52-Week Range
$0.02
Now: $0.59
$0.85
Volume248,867 shs
Average Volume432,643 shs
Market Capitalization$43.97 million
P/E RatioN/A
Dividend YieldN/A
Beta0.77

SEC Filings

Enzon Pharmaceuticals (OTCMKTS:ENZN) SEC Filings

DateFilerForm TypeView
01/04/2021
3:10 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2020
3:17 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/23/2020
11:15 PM
Enzon Pharmaceuticals (Filer)
Form EFFECT
11/18/2020
5:16 PM
Enzon Pharmaceuticals (Issuer)
READ RANDOLPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2020
5:11 PM
Bleznick Jordan (Reporting)
Enzon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
3:16 PM
Enzon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2020
3:44 PM
Enzon Pharmaceuticals (Filer)
Form DEFA14A
11/03/2020
3:43 PM
Enzon Pharmaceuticals (Filer)
Form DEF 14A
11/03/2020
3:43 PM
Enzon Pharmaceuticals (Filer)
Form DEF 14A
10/14/2020
4:00 PM
Enzon Pharmaceuticals (Issuer)
ICAHN CARL C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:58 PM
Enzon Pharmaceuticals (Subject)
ICAHN CARL C (Filed by)
Form SC 13D/A
10/14/2020
3:51 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2020
3:17 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2020
8:00 AM
Enzon Pharmaceuticals (Filer)
Form 424B3
09/21/2020
11:15 PM
Enzon Pharmaceuticals (Filer)
Form EFFECT
09/17/2020
3:12 PM
COUCHMAN JONATHAN (Filed by)
Enzon Pharmaceuticals (Subject)
Form SC 13D/A
09/15/2020
3:20 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2020
8:11 AM
Enzon Pharmaceuticals (Filer)
Form S-1/A
09/02/2020
3:22 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
3:15 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
3:12 PM
Enzon Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/31/2020
3:45 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2020
3:49 PM
Couchman Family Fund (Reporting)
COUCHMAN JONATHAN (Reporting)
Enzon Pharmaceuticals (Issuer)
HARPER ASSET MANAGEMENT LLC (Reporting)
Harper Brian James (Reporting)
Myrexis, Inc. (Reporting)
Pearce Michael Cooper (Reporting)
Xstelos Corp. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
7:36 PM
Bleznick Jordan (Reporting)
Enzon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2020
4:10 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2020
4:08 PM
Enzon Pharmaceuticals (Filer)
Form 8-A12G
08/14/2020
10:32 AM
Enzon Pharmaceuticals (Issuer)
READ RANDOLPH C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2020
8:45 PM
Enzon Pharmaceuticals (Subject)
ICAHN CARL C (Filed by)
Form SC 13D/A
08/07/2020
4:33 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
5:34 PM
Couchman Family Fund (Reporting)
COUCHMAN JONATHAN (Reporting)
Enzon Pharmaceuticals (Issuer)
Myrexis, Inc. (Reporting)
Xstelos Corp. (Reporting)
Form 4/A
03/31/2020
5:30 PM
Enzon Pharmaceuticals (Issuer)
Myrexis, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2020
7:31 PM
Couchman Family Fund (Reporting)
COUCHMAN JONATHAN (Reporting)
Enzon Pharmaceuticals (Issuer)
Xstelos Corp. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2020
4:27 PM
COUCHMAN JONATHAN (Filed by)
Enzon Pharmaceuticals (Subject)
Form SC 13G/A
01/22/2020
4:06 PM
Enzon Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
01/16/2020
6:37 AM
Enzon Pharmaceuticals (Subject)
HARPER ASSET MANAGEMENT LLC (Filed by)
Form SC 13G/A
08/22/2019
4:23 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
6:37 AM
Enzon Pharmaceuticals (Filer)
Form DEFA14A
07/12/2019
6:36 AM
Enzon Pharmaceuticals (Filer)
Form DEF 14A
05/08/2019
3:16 PM
Enzon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
3:16 PM
Enzon Pharmaceuticals (Filer)
Form 10-K/A
02/21/2019
3:07 PM
Enzon Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
8:55 PM
Couchman Family Fund (Reporting)
COUCHMAN JONATHAN (Reporting)
Enzon Pharmaceuticals (Issuer)
Xstelos Corp. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:10 PM
Enzon Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
01/09/2019
7:53 PM
Couchman Family Fund (Reporting)
COUCHMAN JONATHAN (Reporting)
Enzon Pharmaceuticals (Issuer)
Xstelos Corp. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
7:49 PM
Couchman Family Fund (Reporting)
COUCHMAN JONATHAN (Reporting)
Enzon Pharmaceuticals (Issuer)
Xstelos Corp. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
11:38 AM
Enzon Pharmaceuticals (Subject)
HARPER ASSET MANAGEMENT LLC (Filed by)
Form SC 13G/A
11/07/2018
3:14 PM
Enzon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2018
6:32 AM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
3:16 PM
Enzon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/29/2018
6:34 AM
Enzon Pharmaceuticals (Filer)
Form DEFA14A
06/29/2018
6:30 AM
Enzon Pharmaceuticals (Filer)
Form DEF 14A
05/10/2018
4:02 PM
Enzon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2018
3:31 PM
Enzon Pharmaceuticals (Filer)
Form 10-K/A
04/13/2018
3:37 PM
Couchman Family Fund (Reporting)
COUCHMAN JONATHAN (Reporting)
Enzon Pharmaceuticals (Issuer)
Xstelos Corp. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/13/2018
1:59 PM
COUCHMAN JONATHAN (Filed by)
Enzon Pharmaceuticals (Subject)
Form SC 13G/A
04/12/2018
4:07 PM
COUCHMAN PARTNERS LP (Filed by)
Enzon Pharmaceuticals (Subject)
Form SC 13G/A
03/21/2018
4:07 PM
Enzon Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2018
3:34 PM
Enzon Pharmaceuticals (Filer)
Form 15-12G
02/09/2018
4:13 PM
Enzon Pharmaceuticals (Subject)
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
01/22/2018
4:14 PM
Enzon Pharmaceuticals (Subject)
HARPER ASSET MANAGEMENT LLC (Filed by)
Form SC 13G
This page was last updated on 2/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.